BRIEF published on 10/24/2024 at 07:35, 28 days 6 hours ago Rentschler Biopharma's Major Investment in German Headquarters Investment Rentschler Biopharma Biopharmaceuticals Facility Expansion Laupheim
PRESS RELEASE published on 10/24/2024 at 07:30, 28 days 6 hours ago Rentschler Biopharma announces largest single investment at its headquarters in Germany Rentschler Biopharma announces largest single investment at its headquarters in Germany to construct a new buffer media facility, enhancing production efficiency and sustainability Innovation Investment Germany Rentschler Biopharma Biopharmaceuticals
BRIEF published on 09/03/2024 at 13:05, 2 months 18 days ago Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox Gene Therapy Advanced Therapies Biopharmaceuticals Lentiviral Vectors Manufacturing Services
PRESS RELEASE published on 09/03/2024 at 13:00, 2 months 18 days ago Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies Rentschler Biopharma launches new lentiviral vector manufacturing toolbox for advanced therapies at UK site, enhancing advanced therapy offerings Gene Therapy Advanced Therapies Rentschler Biopharma Lentiviral Vector Manufacturing Toolbox
BRIEF published on 07/11/2024 at 14:05, 4 months 9 days ago Rentschler Biopharma Unveils New Production Line in Massachusetts Rentschler Biopharma Biopharmaceuticals Massachusetts Production Line
PRESS RELEASE published on 07/11/2024 at 14:00, 4 months 9 days ago Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational Rentschler Biopharma SE announces full operational status of new state-of-the-art production line in Massachusetts, marking largest expansion in company's history Expansion Manufacturing Biopharmaceuticals Rentschler Biopharma SE State-of-the-art Production Line
BRIEF published on 05/28/2024 at 13:05, 5 months 24 days ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
PRESS RELEASE published on 05/28/2024 at 13:00, 5 months 24 days ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management, demonstrating commitment to client centricity and global business development Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer Alliance Management
BRIEF published on 05/02/2024 at 14:15, 6 months 18 days ago Rentschler Biopharma Promotes Patrick Cushing as VP Operations for U.S. Subsidiary Operational Management Rentschler Biopharma Biopharmaceuticals Manufacturing Expansion Patrick Cushing
PRESS RELEASE published on 05/02/2024 at 14:10, 6 months 18 days ago Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary Rentschler Biopharma appoints Patrick Cushing as VP Operations for U.S. subsidiary, showcasing commitment to delivering high-quality services and expanding production capacity Expansion Rentschler Biopharma Biopharmaceutical Manufacturing Patrick Cushing VP Operations
Published on 11/21/2024 at 13:30, 21 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 21 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 51 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 51 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 51 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 16 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 36 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 53 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 31 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 6 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 6 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
